Bessemer Group’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,792
Closed -$26K 2044
2023
Q4
$26K Buy
+1,792
New +$25K ﹤0.01% 1431
2023
Q1
Sell
-1,491
Closed -$23K 1921
2022
Q4
$23K Buy
1,491
+41
+3% +$635 ﹤0.01% 1282
2022
Q3
$22K Buy
1,450
+276
+24% +$4.57K ﹤0.01% 1341
2022
Q2
$19K Buy
+1,174
New +$20.1K ﹤0.01% 1261
2021
Q3
Sell
-3,630
Closed -$105K 1657
2021
Q2
$105K Hold
3,630
﹤0.01% 938
2021
Q1
$95K Buy
+3,630
New +$103K ﹤0.01% 889

Other funds holding BMEZ

Bessemer Group's BMEZ Position: Q1 2024 in Review

Bessemer Group sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2024, closing a stake of 1,792 shares — an estimated $26K sold.

Bessemer Group first reported a position in BMEZ in Q1 2021 and held it in 6 quarters. The position peaked at $105K in Q2 2021. 99 funds tracked by Wall St. Rank hold BMEZ as of Q1 2024.

  • Bessemer Group reported no remaining BlackRock Health Sciences Trust II position as of Q1 2024 after selling out during the quarter.
  • Bessemer Group sold 1,792 BlackRock Health Sciences Trust II shares in Q1 2024, an estimated $26K.
  • Bessemer Group first reported a position in BlackRock Health Sciences Trust II in Q1 2021 and held it in 6 quarters.
  • Bessemer Group's BlackRock Health Sciences Trust II position peaked at $105K in Q2 2021.
  • 99 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2024.

Based on Bessemer Group's 13F filing for Q1 2024, filed 13 May 2024.